Gruber, L., Abdelfatah, S., Fröhlich, T., Reiter, C., Klein, V., Tsogoeva, S. B., & Efferth, T. (2018). Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds. Molecules.
Chicago-stil citatGruber, Lisa, Sara Abdelfatah, Tony Fröhlich, Christoph Reiter, Volker Klein, Svetlana B. Tsogoeva, och Thomas Efferth. "Treatment of Multidrug-Resistant Leukemia Cells By Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds." Molecules 2018.
MLA-referensGruber, Lisa, et al. "Treatment of Multidrug-Resistant Leukemia Cells By Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds." Molecules 2018.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.